Health Economics

  • A US term for sub-sections of health care expenditures like pharmacy, mental health, neonatal or substance abuse treatment costs. They may be specifically identified in order to protect them in cost-reducing initiatives or to accord them special subsidies in order to retain their consumers in an insurance scheme.